CVS Caremark Corp


  • Caremark Rx said on Friday a second request for information from U.S. antitrust regulators into a takeover offer from Express Scripts is evidence the bid from the rival pharmacy benefit manager may not be able to be completed.

  • CVS sweetened its $23.9 billion takeover bid for Caremark on Thursday with an increaseddividend, calling its newest proposal its "best and final" offer for the pharmacy-benefits manager.

  • Battle-Tested Buys Wednesday, 7 Mar 2007 | 6:10 PM ET

    Right now, the best move for investors is to find stocks that made it through the sell-off without a scratch. Luckily, Cramer’s here to help.

  • It's Time for the Lightning Round! Monday, 5 Mar 2007 | 7:02 PM ET

    Callers question Cramer about CVS, Medtronic, JPMorgan Chase and more...

  • Caremark Posts Higher Quarterly Profit, Revenue Wednesday, 21 Feb 2007 | 3:13 PM ET

    Pharmacy benefits manager and takeover target Caremark Rx on Tuesday reported higher earnings and net revenue for the fourth quarter, driven by an increase in retail and mail sales.

  • Caremark attorney Robert Thornton presented a document that he said showed that Express Scripts considered killing the CVS deal to be a successful outcome even if its own offer was rejected.

  • Caremark Vote Delayed After CVS Sweetens Takeover Bid Tuesday, 13 Feb 2007 | 4:51 PM ET

    A Delaware judge ordered Caremark Rx to delay a shareholder vote on a proposed acquisition by CVS just hours after the drugstore operator tripled the special cash dividend it proposes to pay as part of the deal.

  • Caremark Shareholder Adviser Opposes CVS Deal Monday, 12 Feb 2007 | 2:47 PM ET

    CtW said it would be urging Caremark shareholders, including the pension funds and investment managers, to vote against the deal.

  • Proxy advisory firm Glass Lewis said on Friday it recommended that shareholders of Caremark Rx  reject the planned $24 billion takeover by drug-store chain CVS.

  • The pharmacy benefits company reported a 32% increase in fourth-quarter earnings and raised its outlook for the first quarter.

  • CVS Profit Rises 3%, Outpacing Analysts' Estimates Thursday, 1 Feb 2007 | 10:44 AM ET

    The No. 2 U.S. drugstore chain posted a 3% increase in quarterly profit on Thursday, driven by strong sales of prescription medications and greater use of generic drugs, which are more profitable for pharmacies.

  • Eulogy for M&A's--Analysts Say No Funeral Yet Friday, 26 Jan 2007 | 3:00 PM ET

    R.I.P., M&A? Not according to two merger-watchers, who reassured "Power Lunch" viewers that corporate combinations are alive and well -- regardless of interest-rate fluctuation fears. Gerald Adolph, senior vice president at Booz, Allen Hamilton, told CNBC's Sue Herera that M&A doubters describe a twin-pronged nightmare....

  • Caremark Urges Shareholders to Vote for CVS Deal Tuesday, 23 Jan 2007 | 9:50 AM ET

    Caremark Rx said on Tuesday it sent a letter urging its shareholders to support the $24 billion acquisition by drug-store retail chain CVS  and reject a $25 billion hostile takeoveroffer from Express Scripts.

  • Rite Aid shareholders overwhelmingly approved a nearly $3 billion deal to buy more than 1,800 Brooks and Eckerd stores and become the largest drugstore operator on the East Coast.

  • Caremark Stock Up on Speculation of Bidding War Wednesday, 17 Jan 2007 | 12:03 PM ET

    Caremark Rx shares rose sharply after drugstore chain CVS sweetened its bid for the pharmacy benefit manager and analysts projected Express Scripts could counter with a higher offer.

  • "Bad Day" For Intel and Pickens on Oil Wednesday, 17 Jan 2007 | 8:12 AM ET

    Stocks in the U.S. are seeking direction and are looking mostly higher in mixed action ahead of the open. Earnings news from big names like Intel and J.P. Morgan are making headlines, and the markets are watching for PPI inflation data this morning and the Fed's Beige Book at 2 pm. Oil slumped below $51 a barrel this morning after a deep slide yesterday.

  • Express Scripts Launches $25 Billion Offer for Caremark Tuesday, 16 Jan 2007 | 12:00 PM ET

    Pharmacy-benefits manager Express Scripts said it was starting a $25 billion exchange offer for all outstanding shares of rival Caremark Rx , despite drugstore operator CVS' bid for the company.

  • Stocks closed higher after bargain hunters stepped in to drive up shares of financials, technology and industrials.

  • Express Scripts confirmed its plans to launch a proxy battle for four seats on Caremark's board, as reported by CNBC's David Faber.

  • Much "Ado" Today For Markets And CNBC Monday, 8 Jan 2007 | 8:08 AM ET

    Stocks in the U.S. for now look set for a firmer open on what promises to be a busy day in the markets and a busy day on CNBC. Our correspondents are at major conferences across the U.S. Phil Lebeau is at the auto show in Detroit, where the industry is unveiling new products. Jim Goldman is bringing us the latest tech gadgets from the Consumer Electronics show in Las Vegas....